Assistance Publique - Hôpitaux de Paris: Carcinoma, Hepatocellular trials
The registry lists 37 Carcinoma, Hepatocellular studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 12 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 7Phase 3 6No phase 25(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Liver Transplant for Hepatocellular CarcinomaNot yet recruitingNCT07629193
- Impact of the Procurement Technique on Outcomes After Liver TransplantationNot yet recruitingNCT07582978
- Liver Diseases: Extracellular Vesicles as BiomarkersNot yet recruitingNCT07185360Not applicable
- Impact of Comprehensive Geriatric Management on Morbidity and Quality of Life in Elderly Patients Undergoing Major Hepatectomy and Pancreaticoduodenectomy for CancerNot yet recruitingNCT06999512Phase 2/3
- SIRT and Peri-immunotherapy : a New ConceptNot yet recruitingNCT06971237
- Multi-modal Characterisation of Hepatocellular Carcinoma (HCC) Treated with Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National CohortRecruitingNCT06334965Not applicable
- Evaluation of Stereotactic Body Radiotherapy as a Bridge Therapy for Hepatocellular Carcinoma Patients Enlisted for Liver TransplantationRecruitingNCT06218420Phase 2
- Resection And Partial LIver Transplantation With Delayed Hepatectomy for Hepatocellular CarcinomaNot yet recruitingNCT05971628Not applicable
- METabolic PROFILE of Hepatocarcinoma and Pancreatic TumorsRecruitingNCT05794048Not applicable
- Glypican-3 as a Prognostic Factor in Patients With Hepatocellular Carcinoma Treated by ImmunotherapyRecruitingNCT05263830
- FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer.RecruitingNCT05095714Not applicable
- Cohort of Patients With Hepatocellular Carcinoma or CholangiocarcinomaRecruitingNCT04340986
- Durvalumab/Tremelimumab in Neoadjuvant and Adjuvant Setting in Patients With HCC Treated by by Percutaneous Ablation ProcedureActive, not recruitingNCT06045975Phase 2
- Lenvatinib Treatment in Waiting List of Liver Transplantation After TACE Failure in Patients With Hepatocellular CarcinomaActive, not recruitingNCT05901194Phase 1/2
- Identification of Image Phenotypes to Predict Recurrence After Resection of Hepatocellular CarcinomaCompletedNCT05235490
- Neoadjuvant and Adjuvant Lenvatinib in HCC Patients Treated by Percutaneous AblativeActive, not recruitingNCT05113186Phase 2
- Immune Cells as a New Biomarker of Response in Patients Treated by Immunotherapy for Advanced Hepatocellular CarcinomaTerminatedNCT05044676
- Perception of the Doctor/Patient Relationship, Disease and Treatment Among Physicians and Their Patients Treated With Systemic Therapy for Hepatocellular Carcinoma "PERCEPTION1"CompletedNCT04823754
- Value of the Laparoscopic Approach in the Surgical Management of Resectable Hepatocellular CarcinomaActive, not recruitingNCT04791735Not applicable
- Phenotyping Liver Cancer RegistryCompletedNCT04681274
- Study of Automatic Image Fusion of a CT Volume With Ultrasound During Percutaneous Ablation Treatment of Hepatic TumorsCompletedNCT04420026Not applicable
- Combination PET With 18F-fluorodeoxyglucose (18F-FDG) and 18 F-choline in Patient With HCCCompletedNCT04391348Not applicable
- Interest of the Intervention of a Nurse Coordinator in Complex Care PathwayStatus unknownNCT04209491
- Perfusion and Dual Energy Computer Tomography in Hepatocellular CarcinomaStatus unknownNCT03754192Not applicable
- Neoadjuvant and Adjuvant Nivolumab in HCC Patients Treated by ElectroporationTerminatedNCT03630640Phase 2
- Interest of elastoFRM With Force Measure by MRI on Patients With Hepatocellular CancerCompletedNCT02929082Not applicable
- Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and CholangiocarcinomaCompletedNCT02730611
- Primary Prevention Hepatocellular Carcinoma by MetforminTerminatedNCT02319200Phase 3
- Major RF Ablations of Hepatomas Under MR Thermometry MonitoringTerminatedNCT01486134Not applicable
- SorAfenib Versus RADIOEMBOLIZATION in Advanced Hepatocellular CarcinomaCompletedNCT01482442Phase 3
- Phlebotomy and Risk of Hepatocellular Carcinoma in Patients With Compensated Alcoholic CirrhosisTerminatedNCT01342705Phase 3
- Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar CarcinomaTerminatedNCT01215565Phase 2
- Study of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma (HCC)CompletedNCT01198704
- Multipolar Radiofrequency Ablation for Hepatocellular Carcinoma Using Extra Nodular Versus Intranodular TechniqueCompletedNCT01008657Not applicable
- Parenchyma Resection of Cirrhotic Liver by the Clamp Crushing Technique and the Ultrasonic DissectorTerminatedNCT00763776Not applicable
- Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic PatientsTerminatedNCT00470340Phase 3
- Screening of Hepatocellular Carcinoma in Patients With Compensated CirrhosisCompletedNCT00190385Phase 3